Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMMUS: DVS SR Titration and Tapering in Menopause
NCT00401245Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of desvenlafaxine in vasomotor symptoms, sponsored by Pfizer. Started Dec 2006; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00401245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401245.